This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Martin, D. S. Articles by Young, C. W. Search for Related Content PubMed PubMed Citation Articles by Martin, D. S. Articles by Young, C. W.

High-Dose 5-Fluorouracil with Delayed Uridine "Rescue" in Mice¹

Institute of Cancer Research Columbia University, New York, New York 10033 [D. S. M., R. L. S., R. C. S., S. S.]; Department of Developmental Chemotherapy, Memorial Sloan-Kettering Cancer Institute, New York, New York 10021 [D. S. M., C. W. Y.]; and Department of Surgery, Catholic Medical Center, New York, New York 11421 [D. S. M., R. L. S., R. C. S.]

Because of the association between the incorporation of 5-fluorouracil (FUra) into RNA and cytotoxicity, uridine was examined for potential selective reduction of host toxicity. Male BALB/c x DBA/2 F₁ mice (tumor free or bearing advanced colon tumor 26) were used. Two uridine schedules (each beginning 2 hr after FUra) have been successful: (a) uridine at 800 mg/kg every 2 hr for three doses followed 18 hr later by uridine at 800 mg/kg every 2 hr for four doses; or (b) two doses of uridine at 3500 mg/kg separated by an 18-hr interval. With two doses of uridine at 3500 mg/kg, the 50% lethal dose for a single dose of FUra in tumor-free mice was increased 68% from 190 to 320 mg/kg. White blood cell levels were depressed 67% after a single dose of FUra at 200 mg/kg, whereas white blood cells were depressed by only 39% when the same dose of FUra was followed by uridine rescue.

In tumor-bearing mice, uridine rescue reduced FUra-induced host toxicity without significant loss of antitumor activity. Even more striking results were obtained with a combination containing N-(phosphonacetyl)-L-aspartate (200 mg/kg) and 6-methylmercaptopurine riboside (25 mg/kg), administered 24 hr before FUra. In this drug combination, the maximum tolerated dose of FUra is 40 mg/kg on a weekly schedule. With uridine rescue, FUra can be doubled to 80 mg/kg without increasing toxicity, resulting in significantly improved antitumor activity. Examination of the effect of uridine rescue on the incorporation of FUra into RNA and the subsequent recovery from inhibition of DNA symthesis in bone marrow versus tumor revealed that the uridine rescue schedule resulted in relatively faster clearance of FUra from RNA of both tissues but a striking enhancement of the rate of recovery of DNA synthesis only in the bone marrow.

¹ Supported in part by National Cancer Institute Grant 1 PO1 CA25842-O1A1 and in part by the Chemotherapy Foundation, New York.

² To whom requests for reprints should be addressed, at St. Anthony's Cancer Research Cente,r 89-15 Woodhaven Boulevard, New York, N. Y. 11421.

Received 2/16/82. Accepted 7/ 8/82.

This article has been cited by other articles:

				M. P. Liu, L. Beigelman, E. Levy, R. E. Handschumacher, and G. Pizzorno Discrete roles of hepatocytes and nonparenchymal cells in uridine catabolism as a component of its homeostasis Am J Physiol Gastrointest Liver Physiol, June 1, 1998; 274(6): G1018 - G1023. [Abstract] [Full Text] [PDF]

				D. M. Pritchard, A. J. M. Watson, C. S. Potten, A. L. Jackman, and J. A. Hickman Inhibition by uridine but not thymidine of p53-dependent intestinal apoptosis initiated by 5-fluorouracil: Evidence for the involvement of RNA perturbation PNAS, March 4, 1997; 94(5): 1795 - 1799. [Abstract] [Full Text] [PDF]